COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Symposia


Postponed:  TBD 2021

Location:  La Jolla Institute for Immunology

Hosted by: Drs. Nisarg Shah, Ezra Cohen and Stephen Schoenberger

 

David Mooney, PhD
Professor of Bioengineering
Harvard School of Engineering

​Keynote
David Mooney is the Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute. He received his B.S. in Chemical Engineering from the University of Wisconsin, and Ph.D. in Chemical Engineering from MIT. His laboratory designs biomaterials to make cell and protein therapies effective and practical approaches to treat disease. He is a member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. He has won numerous awards, including the Clemson Award from the SFB, MERIT award from the NIH, Distinguished Scientist Award from the IADR, Phi Beta Kappa Prize for Excellence in Undergraduate Teaching, and the Everett Mendelsohn Excellence in Mentoring Award from Harvard College. His inventions have been licensed by numerous companies, leading to commercialized products, and he is active on industrial scientific advisory boards.

Yvonne Chen, PhD
Associate Professor
Department of Microbiololgy,
Immunology, and Molecular Genetics
Uuniversity of California, Los Angeles

 

​Keynote
Dr. Yvonne Chen is an Associate Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. She is also a faculty, by courtesy, in the Department of Chemical and Biomolecular Engineering. Yvonne received her B.S. in Chemical Engineering from Stanford University and her Ph.D. in Chemical Engineering from the California Institute of Technology. She received postdoctoral training at the Seattle Children’s Research Institute and the Department of Systems Biology at Harvard Medical School. Prior to joining UCLA in 2013, Yvonne was a Junior Fellow in the Harvard Society of Fellows. The Chen Laboratory focuses on applying synthetic biology and biomolecular engineering techniques to the development of novel mammalian-cell systems. The Chen Lab’s work on engineering next-generation T-cell therapies for cancer has been recognized by the NIH Director’s Early Independence Award, the NSF CAREER Award, the Hellman Fellowship, the ACGT Young Investigator Award in Cell and Gene Therapy for Cancer, the Mark Foundation Emerging Leader Award, and the Cancer Research Institute Lloyd J. Old STAR Award.

Alexander Cheung, PhD
Chief Scientific Officer
Immulus, Inc.

Alexander Cheung is the CSO of Immulus, Inc. Immulus builds bioinstructive materials to program immune cell functions. Alex is a biomedical engineer with expertise in materials science and T cell therapy manufacturing. Alex earned his Ph.D. from Harvard University where he developed biomaterial platforms for immuno-oncology applications. He has experience in downstream process development for T cell drug product development, design and implementation of automated laboratory and data analytics pipelines for process development scaleout, and analytical development for drug product potency testing.

Prashant Mali, PhD
Assistant Professor
Departments of Bioengineering
University of California, San Diego

Prashant Mali, Ph.D., is an Assistant Professor in the Department of Bioengineering at the University of California, San Diego. His research is in the fields of synthetic biology and regenerative medicine, with a long-term focus on developing tools for enabling gene and cell based human therapeutics. Prashant received his Bachelor’s and Master’s degrees in Electrical Engineering from the Indian Institute of Technology Bombay, a doctorate in Biomedical Engineering at the Johns Hopkins University, and a postdoctoral fellowship in the Department of Genetics at the Harvard Medical School. He has received multiple awards including the Siebel Scholar Award, the Burroughs Wellcome Career Award at the Scientific Interface, the March of Dimes Basil O’Conner Scholar Award, the Kimmel Scholar Award, Kavli Frontiers of Science Fellow, and the Young Alumnus Achiever Award from the Indian Institute of Technology Bombay.

Anjana Rao, PhD
Professor, Division of Signaling and
Gene Expression
La Jolla Institute for Immunology
Dr. Anjana Rao obtained her Ph.D. in Biophysics from Harvard University and was a Professor at Harvard Medical School until 2011, when she moved to the La Jolla Institute and UCSD (University of California in San Diego). Her research is focused on the regulation of gene expression, using immune cells, haematopoietic stem cells and embryonic stem cells as model systems. Her lab purified and molecularly characterized the calcium/ calcineurin-regulated transcription factor NFAT; defined diverse transcriptional programs regulated by NFAT proteins in T cells; identified the pore subunit of the store-operated Ca2+ channel, ORAI1; and discovered that proteins of the TET family are enzymes that mediate DNA demethylation and regulate gene expression by oxidizing 5-methylcytosine. In recent studies, her lab has defined the role of NFAT and other transcription factors in anti-tumor responses, and explored the roles of TET proteins and oxidized methylcytosines in the immune/ haematopoietic systems and in embryonic development and oncogenesis. Dr. Rao is an elected member/fellow of the US National Academy of Sciences, the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and has received an Outstanding Investigator Award from the National Cancer Institute, National Institutes of Health, USA. She has mentored more than 100 students and post-doctoral fellows, many of whom have gone on to leadership positions in science-related fields.

Nicole Steinmetz, PhD
Professor of Nanoengineering
University of California, San Diego

Dr. Steinmetz is a Professor of NanoEngineering at the University of California, San Diego (07/2018-present). She also is the founding Director of the Center for Nano-ImmunoEngineering (nanoIE). She started her independent career at Case Western Reserve University School of Medicine in the Department of Biomedical Engineering (in 2010), where she was promoted through the ranks of Assistant, Associate, and Full Professor. Dr. Steinmetz trained at The Scripps Research Institute, La Jolla, CA where she was a NIH K99/R00 awardee and AHA post-doctoral fellow (2007-2010); she obtained her PhD in Bionanotechnology from the University of East Anglia where she prepared her dissertation as a Marie Curie Early Stage Training Fellow at the John Innes Centre, Norwich, UK (2004-2007). Her early training was at the RWTH-Aachen University in Germany. Dr. Steinmetz’s research program focuses on the engineering of plant virus-based nanomaterials targeting human and plant health applications, such as drug delivery, molecular imaging, and next-generation vaccines and immunotherapies. Dr. Steinmetz has authored more than 150 journal articles. Dr. Steinmetz is a standing member of the NIH Nanotechnology study section. She serves on the Editorial Board of Wiley Interdisciplinary Reviews (WIREs) on Nanomedicine and Nanobiotechnology; she serves on the Advisory Editorial Board for the ACS journal Molecular Pharmaceutics and RSC Journal of Materials Chemistry B. Dr. Steinmetz is a Fellow of the Royal Society of Chemistry (FRSC, since 2018), a Fellow the American Institute of Medical and Biological Engineering (AIMBE, since 2017); she has won many awards, including an American Cancer Society (ACS) Research Scholar Award (2016), and a Young Innovator of Cellular and Molecular Bioengineering Award from the Biomedical Engineering Society (2015).

*As presenters are confirmed, they will be added above.

 To learn more about partnering with SDCPI:  sdcpi@ucsd.edu.


 

SDCPI Symposium Sponsorship Packages